Abstract
Introduction: Mitochondrial-associated ER membranes (MAMs) control many cellular functions, including calcium and lipid exchange, intracellular trafficking, and mitochondrial biogenesis. The disruption of these functions contributes to neurocognitive disorders, such as spatial memory impairment and premature brain aging. Using neuronal cells, we demonstrated that HIV-1 Tat protein deregulates the mitochondria. Methods& Results: To determine the mechanisms, we used a neuronal cell line and showed that Tat-induced changes in expression and interactions of both MAM-associated proteins and MAM tethering proteins. The addition of HIV-1 Tat protein alters expression levels of PTPIP51 and VAPB proteins in the MAM fraction but not the whole cell. Phosphorylation of PTPIP51 protein regulates its subcellular localization and function. We demonstrated that the Tat protein promotes PTPIP51 phosphorylation on tyrosine residues and prevents its binding to VAPB. Treatment of the cells with a kinase inhibitor restores the PTPIP51-VAPB interaction and overcomes the effect of Tat. Conclusion: These results suggest that Tat disrupts the MAM, through the induction of PTPIP51 phosphorylation, leading to ROS accumulation, mitochondrial stress, and altered movement. Hence, we concluded that interfering in the MAM-associated cellular pathways contributes to spatial memory impairment and premature brain aging often observed in HIV-1-infected patients.
Original language | English |
---|---|
Pages (from-to) | 365-377 |
Number of pages | 13 |
Journal | CNS Neuroscience and Therapeutics |
Volume | 29 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2023 |
Keywords
- HIV-1-tat
- MAM-tethering
- PTPIP51
- VAPB
- aging
- memory impairment
- mitochondria-associated ER membranes
- Mitochondria/metabolism
- Humans
- Protein Tyrosine Phosphatases/metabolism
- HIV-1/metabolism
- Gene Products, tat/metabolism
- Endoplasmic Reticulum/metabolism
- Brain/metabolism